MIRM ▲ +1.4% - Mirum Pharmaceuticals, Inc.
$MIRM reported Q3 2026 EPS of -$0.87, missing the -$0.44 estimate by 97.7%. Revenue of $185.7M beat the $177.7M estimate by 4.5%.
03-NOV-2026 04:12 PM ET
Share this post
More filings for $MIRM
MIRM ▲ +0.0% - Mirum Pharmaceuticals, Inc.Nov 2, 2026MIRM ▲ +5.3% - Mirum Pharmaceuticals, Inc.Oct 12, 2026MIRM ▲ +8.7% - Mirum Pharmaceuticals, Inc.Oct 12, 2026MIRM ▲ +5.1% - Mirum Pharmaceuticals, Inc.Sep 28, 2026MIRM ▲ +2.2% - Mirum Pharmaceuticals, Inc.Sep 27, 2026MIRM - Mirum Pharmaceuticals, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $MIRM filing history →💬 Comments
Loading comments…
Leave a comment